FORMULATIONS POUR COMPRIMÉS À LIBÉRATION IMMÉDIATE

• 收藏
• 分享

专利权人:

AstraZeneca AB;AstraZeneca UK Limited

发明人:

申请号：

EP10782116.7

公开号：

EP2498759B1

申请日:

2010.11.12

申请国别(地区):

EP

年份:

2018

代理人:

摘要：

The present invention provides an immediate release pharmaceutical formulation which includes a tablet or capsule formulation comprising metformin and the sodium dependent glucose transporter (SGLT2) inhibitor dapagliflozin or its propylene glycol hydrate. The present invention also provides methods of preparing the formulations and methods of treating diseases or disorders associated with SGLT2 activity employing these formulations.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/